REVIEW ARTICLE
CAQ Corner: Evolution of liver allocation policy
Ammar Hassan,
Pratima Sharma,
Ammar Hassan
Division of Gastroenterology, University of Michigan Health West, Grand Rapids, Michigan, USA
Division of Gastroenterology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA
Search for more papers by this authorCorresponding Author
Pratima Sharma
Division of Gastroenterology, University of Michigan Health West, Grand Rapids, Michigan, USA
Correspondence
Pratima Sharma, Division of Gastroenterology, Michigan Medicine, University of Michigan, 3912, Taubman Center, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USA.
Email: [email protected]
Search for more papers by this authorAmmar Hassan,
Pratima Sharma,
Ammar Hassan
Division of Gastroenterology, University of Michigan Health West, Grand Rapids, Michigan, USA
Division of Gastroenterology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA
Search for more papers by this authorCorresponding Author
Pratima Sharma
Division of Gastroenterology, University of Michigan Health West, Grand Rapids, Michigan, USA
Correspondence
Pratima Sharma, Division of Gastroenterology, Michigan Medicine, University of Michigan, 3912, Taubman Center, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USA.
Email: [email protected]
Search for more papers by this authorFirst published: 09 May 2022
Earn CME and MOC for this article: www.wileyhealthlearning.com/aasld.aspx
CONFLICT OF INTEREST
Nothing to report.
Open Research
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the authors upon reasonable request.
REFERENCES
- 1Freeman RB Jr, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant. 2004; 4(Suppl 9): 114–31.
- 2Schilsky ML, Moini M. Advances in liver transplantation allocation systems. World J Gastroenterol. 2016; 22: 2922–30.
- 3 Institute of Medicine (US). Committee on Organ Procurement and Transplantation Policy. Organ procurement and transplantation: assessing current policies and the potential impact of the DHHS final rule. Washington, DC: National Academies Press (US); 1999.
- 4Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000; 31: 864–71.
- 5Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003; 124: 91–6.
- 6Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R, et al. Results of the first year of the new liver allocation plan. Liver Transpl. 2004; 10: 7–15.
- 7Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl. 2005; 11: 336–43.
- 8Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008; 359: 1018–26.
- 9Sharma P, Schaubel DE, Goodrich NP, Merion RM. Serum sodium and survival benefit of liver transplantation. Liver Transpl. 2015; 21: 308–13.
- 10Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, et al. MELD 3.0: the model for end-stage liver disease updated for the modern era. Gastroenterology. 2021; 161: 1887–95.e4.
- 11 Liver allocation policy. [cited 2022 Feb 14]. Available from: https://optn.transplant.hrsa.gov/media/eavh5bf3/optn_policies.pdf
- 12Freeman RB Jr, Gish RG, Harper A, Davis GL, Vierling J, Lieblein L, et al. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl. 2006; 12(Suppl 3): S128–36.
- 13Aby ES, Lake JR. Basic principles of liver allocation and development over the years. Curr Opin Organ Transplant. 2020; 25: 99–103.
- 14Wedd JP, Harper AM, Biggins SW. MELD score, allocation, and distribution in the United States. Clin Liver Dis. 2013; 2: 148–51.
10.1002/cld.233 Google Scholar
- 15Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Noreen SM, et al. OPTN/SRTR 2017 annual data report: liver. Am J Transplant. 2019; 19(Suppl 2): 184–283.
- 16Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant. 2005; 5: 307–13.
- 17Humar A, Khwaja K, Glessing B, Larson E, Asolati M, Durand B, et al. Regionwide sharing for status 1 liver patients—beneficial impact on waiting time and pre- and posttransplant survival. Liver Transpl. 2004; 10: 661–5.
- 18Sharma P, Schaubel DE, Gong Q, Guidinger M, Merion RM. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates. Hepatology. 2012; 55: 192–8.
- 19Massie AB, Chow EK, Wickliffe CE, Luo X, Gentry SE, Mulligan DC, et al. Early changes in liver distribution following implementation of share 35. Am J Transplant. 2015; 15: 659–67.
- 20Bertsimas D, Papalexopoulos T, Trichakis N, Wang Y, Hirose R, Vagefi PA. Balancing efficiency and fairness in liver transplant access: tradeoff curves for the assessment of organ distribution policies. Transplantation. 2020; 104: 981–7.
- 21Sakamoto S, Uchida H, Takeuchi I, Irie R, Shimizu S, Yanagi Y, et al. Sequential deceased donor intestine transplantation followed by living donor liver transplantation, also known as hybrid intestine-liver transplantation. Transplantation. 2020; 104: e42–3.
- 22 Available from: https://optn.transplant.hrsa.gov/media/53wj54zi/data_report_liver_full_18moallocation_20211203_508_compliant.pdf
- 23Available from: https://unos.org/news/innovation/building-more-flexible-system-for-organallocation/
- 24Cullaro G, Sharma P, Jo J, Rassiwala J, LB VW, Wong R, et al. Temporal trends and evolving outcomes after simultaneous liver-kidney transplantation: results from the US SLKT Consortium. Liver Transpl. 2021; 27: 1613–22.
- 25Formica RN, Aeder M, Boyle G, Kucheryavaya A, Stewart D, Hirose R, et al. Simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of scarce resources. Am J Transplant. 2016; 16: 758–66.
- 26Bari K, Sharma P. Optimizing the selection of patients for simultaneous liver-kidney transplant. Clin Liver Dis. 2021; 25: 89–102.
- 27Samoylova ML, Wegermann K, Shaw BI, Kesseli SJ, Au S, Park C, et al. The impact of the 2017 kidney allocation policy change on simultaneous liver-kidney utilization and outcomes. Liver Transpl. 2021; 27: 1106–15.
